Cargando…

Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis

BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Baozhong, Zhang, Jiandong, Sun, Zejia, Cao, Peng, Zheng, Xiang, Gao, Zihao, Cao, Haoyuan, Zhang, Feilong, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/
https://www.ncbi.nlm.nih.gov/pubmed/33429832
http://dx.doi.org/10.1097/MD.0000000000024257
_version_ 1783633977026805760
author Yu, Baozhong
Zhang, Jiandong
Sun, Zejia
Cao, Peng
Zheng, Xiang
Gao, Zihao
Cao, Haoyuan
Zhang, Feilong
Wang, Wei
author_facet Yu, Baozhong
Zhang, Jiandong
Sun, Zejia
Cao, Peng
Zheng, Xiang
Gao, Zihao
Cao, Haoyuan
Zhang, Feilong
Wang, Wei
author_sort Yu, Baozhong
collection PubMed
description BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include how to diagnose RCC earlier and how to overcome drug resistance. Methods: We explored the relationship between the transcription level of IFI16 and clinical data in RCC through various online databases, including ONCOMINE, GEPIA, HPA, Timer and COEXPEDIA. RESULTS: In comparison with corresponding normal tissues, IFI16 mRNA expression levels were higher in kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) tissues. In KIRC, the higher expression of IFI16 was associated with lower overall survival (P = .037). In KIRP, the higher expression IFI16 was associated with lower disease-free survival and overall survival (P = .037 and P = .011). In contrast, the IFI16 expression was negatively correlated with tumor purity in kidney chromophobe, KIRC and KIRP (all P < .05). In KIRC and KIRP, the expression of IFI16 was positively correlated with tumor-infiltrating immune cells (TIICs) (all P < .05), except macrophages in KIRP. In KIRC, the main TIICs were B cells, CD4(+)T cells, neutrophils, and dendritic cells, while the main TIICs in the high amplification state were macrophage (all P < .0001). Functional enrichment analysis by gene ontology and Kyoto Encyclopedia of Genes and Genomes highlighted enrichment of neutrophil degranulation, phagocytosis and vesicle-mediated transport regulation, and pathways including tuberculosis, toxoplasmosis, phagosome, leishmaniasis, and Fc gamma R-mediated. CONCLUSIONS: IFI16 is overexpressed in RCC and may be an important oncogene in the progression of kidney. In addition, IFI16 may a marker for RCC diagnosis and prognosis, which may be related to immune infiltration.
format Online
Article
Text
id pubmed-7793379
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77933792021-01-11 Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis Yu, Baozhong Zhang, Jiandong Sun, Zejia Cao, Peng Zheng, Xiang Gao, Zihao Cao, Haoyuan Zhang, Feilong Wang, Wei Medicine (Baltimore) 7300 BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include how to diagnose RCC earlier and how to overcome drug resistance. Methods: We explored the relationship between the transcription level of IFI16 and clinical data in RCC through various online databases, including ONCOMINE, GEPIA, HPA, Timer and COEXPEDIA. RESULTS: In comparison with corresponding normal tissues, IFI16 mRNA expression levels were higher in kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) tissues. In KIRC, the higher expression of IFI16 was associated with lower overall survival (P = .037). In KIRP, the higher expression IFI16 was associated with lower disease-free survival and overall survival (P = .037 and P = .011). In contrast, the IFI16 expression was negatively correlated with tumor purity in kidney chromophobe, KIRC and KIRP (all P < .05). In KIRC and KIRP, the expression of IFI16 was positively correlated with tumor-infiltrating immune cells (TIICs) (all P < .05), except macrophages in KIRP. In KIRC, the main TIICs were B cells, CD4(+)T cells, neutrophils, and dendritic cells, while the main TIICs in the high amplification state were macrophage (all P < .0001). Functional enrichment analysis by gene ontology and Kyoto Encyclopedia of Genes and Genomes highlighted enrichment of neutrophil degranulation, phagocytosis and vesicle-mediated transport regulation, and pathways including tuberculosis, toxoplasmosis, phagosome, leishmaniasis, and Fc gamma R-mediated. CONCLUSIONS: IFI16 is overexpressed in RCC and may be an important oncogene in the progression of kidney. In addition, IFI16 may a marker for RCC diagnosis and prognosis, which may be related to immune infiltration. Lippincott Williams & Wilkins 2021-01-08 /pmc/articles/PMC7793379/ /pubmed/33429832 http://dx.doi.org/10.1097/MD.0000000000024257 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7300
Yu, Baozhong
Zhang, Jiandong
Sun, Zejia
Cao, Peng
Zheng, Xiang
Gao, Zihao
Cao, Haoyuan
Zhang, Feilong
Wang, Wei
Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title_full Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title_fullStr Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title_full_unstemmed Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title_short Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
title_sort interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
topic 7300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/
https://www.ncbi.nlm.nih.gov/pubmed/33429832
http://dx.doi.org/10.1097/MD.0000000000024257
work_keys_str_mv AT yubaozhong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT zhangjiandong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT sunzejia interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT caopeng interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT zhengxiang interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT gaozihao interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT caohaoyuan interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT zhangfeilong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis
AT wangwei interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis